Dionne Nolan
Podiatrist · Jonesboro, LANPI 1104897446
Payments from drug & device makers
What this record shows
10 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 59.5% of the total. Reporting peaked in 2023 at $731 and has fallen 98.0% since, to $15 in 2025. That places this record below the midpoint for podiatrist clinicians in LA, where the typical reported total is $2,398.
Across 23 payments — averaging $46.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$641
- Organogenesis Inc.$151
- Stryker$73
- Bioventus LLC$71
- Nevro Corp.$56
- Kowa Pharmaceuticals America, Inc.$21
- plus $64 from 4 others
What the payments were for
- Travel & lodging$62158%
- Food & beverage$45642%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 3 | $641 |
| Organogenesis Inc. | 7 | $151 |
| Stryker | 1 | $73 |
| Bioventus LLC | 4 | $71 |
| Nevro Corp. | 3 | $56 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Smith+Nephew | 1 | $19 |
| Amgen | 1 | $17 |
| AbbVie | 1 | $15 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,078 in reported general payments places this provider in the 40th percentile of 68 podiatrist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 34 | $1,918 |
| Gabapentin | 151 | $1,413 |
| Terbinafine Hcl | 71 | $1,181 |
| Allopurinol | 52 | $611 |
| Meloxicam | 97 | $412 |
| Pregabalin | 40 | $346 |
| Amitriptyline Hcl | 21 | $171 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $151 |
| Febuxostat | 12 | $134 |
| Ciprofloxacin Hcl | 22 | $132 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 28 | $94 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $90 |
| Tramadol Hcl | 13 | $77 |
| Naproxen | 15 | $50 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Jonesboro
- Maxime SavardKenner$74K
- David TranMonroe$24K
- Tyler TewilliagerHouma$16K
- Rustin AjdariSlidell$15K
- Oghale EleyaeNatchitoches$12K
- Rory PanepintoMetairie$12K
- John CarradineMetairie$11K
- John DestefanoFort Polk$10K
- Nneka MekaNew Orleans$9K
- Robert MarroquinMetairie$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.